295 related articles for article (PubMed ID: 25926405)
1. Will use of combination cephalosporin/azithromycin therapy forestall resistance to cephalosporins in Neisseria gonorrhoeae?
Rice LB
Sex Transm Infect; 2015 Jun; 91(4):238-40. PubMed ID: 25926405
[No Abstract] [Full Text] [Related]
2. Gonorrhea Treatment Failures With Oral and Injectable Expanded Spectrum Cephalosporin Monotherapy vs Dual Therapy at 4 Canadian Sexually Transmitted Infection Clinics, 2010-2013.
Singh AE; Gratrix J; Martin I; Friedman DS; Hoang L; Lester R; Metz G; Ogilvie G; Read R; Wong T
Sex Transm Dis; 2015 Jun; 42(6):331-6. PubMed ID: 25970311
[TBL] [Abstract][Full Text] [Related]
3. First line dual therapy for gonorrhoea to limit the spread of antimicrobial resistance.
Mohammed H; Sile B; Furegato M; Woodhall S; Fifer H; Hughes G
BMJ; 2017 Feb; 356():j565. PubMed ID: 28153820
[No Abstract] [Full Text] [Related]
4. Decline in Decreased Cephalosporin Susceptibility and Increase in Azithromycin Resistance in Neisseria gonorrhoeae, Canada.
Martin I; Sawatzky P; Liu G; Allen V; Lefebvre B; Hoang L; Drews S; Horsman G; Wylie J; Haldane D; Garceau R; Ratnam S; Wong T; Archibald C; Mulvey MR
Emerg Infect Dis; 2016 Jan; 22(1):65-7. PubMed ID: 26689114
[TBL] [Abstract][Full Text] [Related]
5. Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010.
Ison CA; Hussey J; Sankar KN; Evans J; Alexander S
Euro Surveill; 2011 Apr; 16(14):. PubMed ID: 21492528
[TBL] [Abstract][Full Text] [Related]
6. Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci.
Tapsall JW
Sex Transm Infect; 2009 Aug; 85(4):256-8. PubMed ID: 19261600
[TBL] [Abstract][Full Text] [Related]
7. Preparing for an era of untreatable gonorrhea.
Barbee LA
Curr Opin Infect Dis; 2014 Jun; 27(3):282-7. PubMed ID: 24685549
[TBL] [Abstract][Full Text] [Related]
8. Potential deleterious effects of promoting the use of ceftriaxone in the treatment of Neisseria gonorrhoeae.
Golden MR; Barbee LA; Kerani R; Dombrowski JC
Sex Transm Dis; 2014 Oct; 41(10):619-25. PubMed ID: 25211259
[TBL] [Abstract][Full Text] [Related]
9. Important treatment change for Neisseria gonorrhoea.
McCarty EJ; Dinsmore WW
J Forensic Leg Med; 2013 Apr; 20(3):181. PubMed ID: 23472801
[No Abstract] [Full Text] [Related]
10. Multidrug-resistant
Terkelsen D; Tolstrup J; Johnsen CH; Lund O; Larsen HK; Worning P; Unemo M; Westh H
Euro Surveill; 2017 Oct; 22(42):. PubMed ID: 29067905
[TBL] [Abstract][Full Text] [Related]
11. Global resistance of Neisseria gonorrhoeae: when theory becomes reality.
Lewis DA
Curr Opin Infect Dis; 2014 Feb; 27(1):62-7. PubMed ID: 24275696
[TBL] [Abstract][Full Text] [Related]
12. Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(31):590-4. PubMed ID: 22874837
[TBL] [Abstract][Full Text] [Related]
13. Treatment of gonococcal infection: when one drug is not enough.
Kransdorf LN; Kling JM; Mayer AP
J Womens Health (Larchmt); 2014 Jul; 23(7):627-8. PubMed ID: 24918549
[No Abstract] [Full Text] [Related]
14. The ticking time bomb: escalating antibiotic resistance in Neisseria gonorrhoeae is a public health disaster in waiting.
Whiley DM; Goire N; Lahra MM; Donovan B; Limnios AE; Nissen MD; Sloots TP
J Antimicrob Chemother; 2012 Sep; 67(9):2059-61. PubMed ID: 22604449
[TBL] [Abstract][Full Text] [Related]
15. Retreatment rates for uncomplicated gonorrhea infection: comparing ceftriaxone and azithromycin versus ceftriaxone and doxycycline.
Schumacher CM; Ghanem KG
Sex Transm Dis; 2013 Jul; 40(7):539-45. PubMed ID: 23965767
[TBL] [Abstract][Full Text] [Related]
16. Delaying the widespread emergence of cephalosporin-resistant gonorrhoea: what is the best target?
Tuddenham S; Ghanem KG
Sex Transm Infect; 2015 Jun; 91(4):232-3. PubMed ID: 25990778
[No Abstract] [Full Text] [Related]
17. Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(26):873-7. PubMed ID: 21734634
[TBL] [Abstract][Full Text] [Related]
18. Cephalosporin and azithromycin susceptibility in Neisseria gonorrhoeae isolates by site of infection, British Columbia, 2006 to 2011.
Hottes TS; Lester RT; Hoang LM; McKay R; Imperial M; Gilbert M; Patrick D; Wong T; Martin I; Ogilvie G
Sex Transm Dis; 2013 Jan; 40(1):46-51. PubMed ID: 23250301
[TBL] [Abstract][Full Text] [Related]
19. Should we still use azithromycin for gonorrhoea treatment?
Mensforth S; Ross JDC
Sex Health; 2019 Sep; 16(5):442-448. PubMed ID: 31207203
[TBL] [Abstract][Full Text] [Related]
20. Neisseria gonorrhoeae with reduced susceptibility to azithromycin--San Diego County, California, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 May; 60(18):579-81. PubMed ID: 21566558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
